Technology | November 13, 2008

im3D is applying CAD methodologies for use in screening and diagnosing a variety of cancer pathologies including breast cancer. Its CAD-BREAST MRI is reportedly an innovative diagnostic and therapy monitoring prototype that applies CAD precision and accuracy to DCE-MRI results. Not only do im3D’s proprietary CAD algorithms reportedly help improve the specificity of DCE-MRI, CAD-BREAST MRI is an intelligent system that automatically calculates and processes the diagnostic parameters used to identify (morphologically) and diagnose a potential tumor in an objective, precise and consistent manner. In other words, CAD-BREAST MRI is able to quantify internationally-accepted measurement standards to deliver not only objective and quantifiable scores but also a mathematical probability of the type of tumor (malignant or benign).


Additional Content

News | Radiology Business

June 6, 2023 — RaySearch Laboratories has announced that New York University (NYU) Langone Hospital - Long Island ...

Time June 06, 2023
arrow
News | Radiology Business

January 18, 2023 — Addressing the growing demand for medical imaging and a shortage of radiologists, Bayer announced the ...

Time January 18, 2023
arrow
News | Artificial Intelligence

December 14, 2022 — Dallas, TX-based MedCognetics, Inc. announced it has received U.S Food and Drug Administration (FDA) ...

Time December 14, 2022
arrow
News | Breast Imaging

November 25, 2022 — Hologic, Inc. will exhibit its extensive portfolio of breast and skeletal health products at the ...

Time November 25, 2022
arrow
News | Digital Pathology

September 13, 2022 — Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has ...

Time September 13, 2022
arrow
Subscribe Now